These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10906736)

  • 1. Identification of the glycosaminoglycan keratan sulfate in the prostatic secretory cell.
    Cohen RJ; Holland JW; Redmond SL; McNeal JE; Dawkins HJ
    Prostate; 2000 Aug; 44(3):204-9. PubMed ID: 10906736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luminal contents of benign and malignant prostatic glands: correspondence to altered secretory mechanisms.
    Cohen RJ; McNeal JE; Redmond SL; Meehan K; Thomas R; Wilce M; Dawkins HJ
    Hum Pathol; 2000 Jan; 31(1):94-100. PubMed ID: 10665919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of the keratan sulfate proteoglycan expressed in prostatic secretory cells and its identification as lumican.
    Holland JW; Meehan KL; Redmond SL; Dawkins HJ
    Prostate; 2004 May; 59(3):252-9. PubMed ID: 15042600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cytoplasmic secretory granules (PSG), in prostatic epithelium and their transformation-induced loss in dysplasia and adenocarcinoma.
    Cohen RJ; McNeal JE; Edgar SG; Robertson T; Dawkins HJ
    Hum Pathol; 1998 Dec; 29(12):1488-94. PubMed ID: 9865837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues.
    Chang SS; Reuter VE; Heston WD; Hutchinson B; Grauer LS; Gaudin PB
    Cancer; 2000 Jan; 88(2):407-15. PubMed ID: 10640975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial differentiation of the lower urinary tract with recognition of the minor prostatic glands.
    Cohen RJ; Garrett K; Golding JL; Thomas RB; McNeal JE
    Hum Pathol; 2002 Sep; 33(9):905-9. PubMed ID: 12378515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and secretory pathways of prostate specific antigen, alpha1-antichymotrypsin and prostate secretory granules in prostate cancers.
    Ishida E; Nakamura M; Shimada K; Kishi M; Nakaoka S; Konishi N
    Pathol Int; 2003 Jul; 53(7):415-21. PubMed ID: 12828605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy.
    Coogan CL; Bostwick DG; Bloom KJ; Gould VE
    Urology; 2003 Jan; 61(1):248-52. PubMed ID: 12559317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyamines in prostatic epithelial cells and adenocarcinoma; the effects of androgen blockade.
    Cohen RJ; Fujiwara K; Holland JW; McNeal JE
    Prostate; 2001 Dec; 49(4):278-84. PubMed ID: 11746274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients.
    Mazzucchelli R; Montironi R; Santinelli A; Lucarini G; Pugnaloni A; Biagini G
    Prostate; 2000 Sep; 45(1):72-9. PubMed ID: 10960845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer.
    Gleave ME; Goldenberg SL; Jones EC; Bruchovsky N; Sullivan LD
    J Urol; 1996 Jan; 155(1):213-9. PubMed ID: 7490838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSP94 expression after androgen deprivation therapy: a comparative study with prostate specific antigen in benign prostate and prostate cancer.
    Imasato Y; Xuan JW; Sakai H; Izawa JI; Saito Y; Chin JL; Moussa M
    J Urol; 2000 Nov; 164(5):1819-24. PubMed ID: 11025776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliable identification of transition zone prostatic adenocarcinoma in preoperative needle core biopsy.
    Lee S; Walsh S; Woods CG; Bonkhoff H; Cohen RJ
    Hum Pathol; 2013 Oct; 44(10):2331-7. PubMed ID: 23954139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent complete androgen blockade in PSA relapse after radical prostatectomy and incidental prostate cancer.
    Kurek R; Renneberg H; Lübben G; Kienle E; Tunn UW
    Eur Urol; 1999; 35 Suppl 1():27-31. PubMed ID: 10081700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
    Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Young CY; Klee GG; Tindall DJ; Bostwick DG
    Urology; 1997 Jun; 49(6):857-62. PubMed ID: 9187691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
    Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
    Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronan-mediated motility receptor (RHAMM) immunohistochemical expression and androgen deprivation in normal peritumoral, hyperplasic and neoplastic prostate tissue.
    Korkes F; de Castro MG; de Cassio Zequi S; Nardi L; Del Giglio A; de Lima Pompeo AC
    BJU Int; 2014 May; 113(5):822-9. PubMed ID: 24053431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
    Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
    Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
    Sinha AA; Sackrison JL; DeLeon OF; Wilson MJ; Gleason DF
    Anat Rec; 1996 Aug; 245(4):652-61. PubMed ID: 8837723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium.
    Ornstein DK; Englert C; Gillespie JW; Paweletz CP; Linehan WM; Emmert-Buck MR; Petricoin EF
    Clin Cancer Res; 2000 Feb; 6(2):353-6. PubMed ID: 10690510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.